Semaglutide and adenosine alleviate obesity-induced kidney injury, with observed modulation of the Txnip/NLRP3 pathway
Semaglutide and adenosine can ameliorate obesity-induced renal injury, potentially through modulation of the Txnip/NLRP3 pathway.
Authors
- Xiaoyu Pan (ORCID: https://orcid.org/0000-0001-6608-2107)
- Shuqi Wang
- Shuchun Chen (ORCID: https://orcid.org/0000-0002-7747-3901)
- Rulian Liang
Institutions
- Hebei Medical University (CN)
- Anhui Medical University (CN)
- Hebei General Hospital (CN)
- Second Affiliated Hospital of Anhui Medical University (CN)
Publication Details
- Journal
- Diabetology & Metabolic Syndrome
- Published
- 2025-05-24
- DOI
- https://doi.org/10.1186/s13098-025-01736-2
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Natural Science Foundation of Hebei Province